NeurogesX Inc
DelistedCIK 1385830fmd_19ZV0ZCPSWC2M4DDG44AN4JXNEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2012, 11 periods
| Line item | FY2009 | FY2010 | FY2011 |
|---|---|---|---|
| Total revenues | 2 | 8 | 12 |
| Cost of revenue | – | 1 | 1 |
| Gross profit | – | 8 | 11 |
| Research and development | 11 | 11 | 14 |
| Selling, general and administrative | 12 | 36 | 36 |
| Total operating expenses | 24 | 48 | 51 |
| Operating income | (22) | (40) | (39) |
| Interest expense | 0 | 5 | 10 |
| Interest and investment income | 0 | 0 | 0 |
| Other non-operating income (expense) | (0) | 1 | (0) |
| Net income | (22) | (45) | (50) |